Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R9 - Effective October 1, 2025

Date Posted: September 4, 2025

This Billing and Coding Article has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: October 1, 2025

Summary of Changes:

Under ICD-10 Codes that Support Medical Necessity Group 1: Codes added C50.A0, C50.A1, C50.A2, Z85.4A, and Z86.00A. This revision is due to the Annual ICD-10-CM Update and will become effective on 10/1/2025.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Sep 04 , 2025